Veeva and Amgen Partner to Speed Up Clinical Trials
Veeva Systems (NYSE: VEEV) has announced a collaboration with Amgen to transform clinical trial operations.
Amgen, a global biotechnology leader, will use the Veeva Clinical Platform to bring greater efficiency and speed to its clinical programs.
The move aligns with Amgen’s mission: accelerate the development of medicines for patients with serious diseases.
Driving Digital Transformation in Trials
Scott Skellenger, Amgen’s Senior Vice President and CIO, said:
“In collaboration with Veeva, we are leveraging advanced technologies to unlock new capabilities for our end-to-end study workflows. This should strengthen our ability to deliver innovative treatments quickly and at scale.”
Jim Reilly, President of Veeva Development Cloud, added:
“We are excited to help Amgen further advance clinical development. The Veeva Clinical Platform will provide the foundation for standardized and connected processes that can accelerate the delivery of life-saving medicines.”
What the Collaboration Includes
Veeva Clinical Platform: an end-to-end system connecting trial workflows and data.
Business Consulting: Veeva will guide Amgen on implementation and change management.
Goal: create streamlined, connected processes that reduce delays and improve trial outcomes.
About the Veeva Clinical Platform
The platform covers the entire clinical lifecycle. Key products include:
CTMS
EDC
Clinical Workbench (CDB)
RTSM
eCOA
eTMF
Site Connect
Study Training
These modules create a connected data flow from trial design to completion, reducing manual work and improving data quality.
About Veeva Systems
Veeva delivers cloud software, data solutions, and consulting for life sciences.
The company serves 1,500+ customers, including major biopharma firms and emerging biotech startups.
As a public benefit corporation, Veeva focuses on aligning the interests of customers, employees, shareholders, and the life sciences industry.
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!